Bone Marrow

Bone Marrow Concentrate (BMC) therapy is a non-surgical stem cell treatment used to treat various orthopedic injuries. BMC is a concentrate of regenerative stem cells obtained from a patient's own bone marrow. In the past, these types of cells were often very difficult and expensive to obtain from the body. With newer techniques and technological improvements, regenerative stem cells can easily be obtained and concentrated by a simple office procedure.

Bone Marrow

BMC accelerates the body's natural healing mechanisms. Unlike other cells, bone marrow concentrate cells have the ability to replicate themselves into a variety of tissue types. When injury occurs, the usual number of regenerative cells needed for tissue regeneration is often inadequate. With BMC, the concentrate of regenerative cells will provide a more robust healing of the damaged tissue and aid in growth and repair. While the full benefits of BMC are still unknown, it has been shown to reduce swelling, relieve pain, and enhance healing of articular cartilage and bone.

Based on current research and clinical experience, BMC stem cell injections for moderate to severe cases of osteoarthritis and severe tendon injuries show promising results. In general, platelet-rich plasma (PRP) may be more appropriate for mild to moderate osteoarthritis or tendon injuries in an active patient. BMC may be reserved for more challenging cases when more potent effects are desired.

Unlike cortisone shots which mask symptoms and can damage tissue, BMC targets the root of the problem and attempts to heal the tissue.

Most patients require only a single BMC stem cell treatment depending on the degree of the injury. This is usually followed by a single PRP injection 6 weeks later to give the body a boost. In challenging cases, however, if a patient experiences significant relief that plateaus, they may consider a second stem cell injection several months or years later.

Bone marrow cancers (such as lymphoma), as well as metastatic disease that spread to the bony spine, as well as any active systemic infection are all contra-indications. Furthermore, blood thinning medication like Coumadin must be discontinued and managed appropriately prior to the procedure.

Most patients notice some level of improvement 2-6 weeks after the injection. Along with a decrease in pain, increased stability and strength are typically reported. This second wave of benefits may be obtained between 6 weeks and 3 months. Patients are encouraged to remain active, strengthen the surrounding muscles, lose weight, and achieve a proper diet and sleep routine.


Neurosurgery Associates

 

Contact Cedar Stem Cell Institute

to set up a complimentary consultation with Dr. Shehadi